Andromedic

What Andromedic does

Andromedic S.r.l. is an Italian medical device company that develops, manufactures, and distributes advanced equipment for deep oncological hyperthermia. Founded in 1994 as Andromedic Italia and spun off in 2012 as a separate entity focused on hyperthermia, the company is headquartered in Velletri (Rome), Italy, and operates as a private limited company with no disclosed external funding. Its flagship product is the HY-DEEP 600WM, a deep capacitive radiofrequency system operating at 13.56 MHz that delivers high-intensity electromagnetic pulses combined with a bio-resonance effect to target solid tumors. The device features patented water-cooled antennas (170mm and 270mm), a Thermal Modulation System using ASK modulation in OOK mode, and dedicated software with indirect temperature calculation algorithms. Andromedic sells to hospitals, oncology clinics, and cancer treatment centers globally through a network of regional distributors covering Asia, the Middle East, Europe, and South Korea, supplemented by direct enterprise sales. Revenue is generated through three models: equipment sales, equipment rental (monthly fee or pay-per-use), and equipment leasing through a financial partnership with BCC Lease. The company holds ISO 13485:2016, CE, Korean GMP, and Korean MFDF certifications, and is governed by three co-founders: Ciro Zaccagnini (President), Ivano Zaccagnini (Production Manager), and Salvatore Conte (Sales Manager and Scientific Director).

Name

Andromedic

Legal name

Andromedic S.r.l.

Website

https://andromedic.it

Company type

Private

Founded year

2012

Operating status

Operating

Short description

Andromedic S.r.l. is an Italian medical device company that develops and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia system sold to hospitals, oncology clinics, and cancer treatment centers worldwide through regional distributors and direct enterprise sales.

Ownership category

akta.pro rank

Product category

Oncological Hyperthermia Medical Devices

NAICS

Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Oncological hyperthermia devices
• Capacitive radiofrequency equipment
• Medical device manufacturing
• Adjuvant cancer therapy systems
• Deep tissue hyperthermia machines

Headquarters

HQ city

Velletri

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Equipment Sales: Sale of HY-DEEP 600WM oncological hyperthermia equipment to healthcare facilities, hospitals, and oncology clinics worldwide
2. Equipment Rental: Flexible rental solutions including monthly fee option for predictable cost management and pay-per-use option based on individual treatments performed. Custom rental solutions available.
3. Equipment Leasing/Financing: Leasing and customized financing solutions in partnership with BCC Lease to support private healthcare facilities and medical professionals in acquiring equipment while spreading costs over time

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Andromedic designs, manufactures, and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia device operating at 13.56 MHz. The system delivers high-intensity electromagnetic pulses combined with a bio-resonance effect to raise tumor tissue temperature to 42.5–43°C as an adjuvant or neo-adjuvant to radiotherapy and chemotherapy, and is sold bundled with patented cooled antennas, dedicated treatment software, and a therapy management PC. Equipment is offered through direct purchase, monthly rental, pay-per-use rental, or BCC Lease-financed leasing to hospitals, oncology clinics, and cancer treatment centers worldwide.

Product overview

Andromedic specializes in developing and manufacturing advanced oncological hyperthermia solutions. The company's flagship product is the HY-DEEP 600WM system, a deep capacitive radiofrequency medical device designed for non-invasive oncological hyperthermia treatment. The system combines electromagnetic wave pulses with bio-resonance technology to target and treat tumors. Andromedic provides complete solutions including proprietary software with automated treatment delivery, patented cooled antennas (170mm and 270mm), antenna spacers, and high-performance PC for treatment management. The equipment is offered through purchase or flexible rental options with financing partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• HY-DEEP 600WM The HY-DEEP 600WM is a deep capacitive radiofrequency oncological hyperthermia device that generates high-intensity electromagnetic pulses at 13.56 MHz combined with a bio-resonance effect to raise target organ or tissue temperature. It is intended as an adjuvant or neo-adjuvant therapy for neoplastic pathologies and concomitant conditions such as infections, inflammation, and pain, and is delivered with patented cooled antennas (170mm and 270mm), antenna spacers, dedicated therapy software with automated data archiving, an indirect temperature calculation algorithm, and a high-performance therapy management PC. The product is sold to hospitals, oncology clinics, and cancer treatment centers and is offered via purchase, monthly rental, pay-per-use rental, or BCC Lease-financed leasing.

Quantifiable outcome

• Therapeutic response improvement of approximately 35% when hyperthermia is added to radiotherapy or chemotherapy
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• VL Holdings LimitedcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Thailand, Vietnam, Malaysia, Singapore, and UAE markets. Located at 65 Julia Street, OCBC Center, Singapore, handling sales and distribution of HY-DEEP 600WM equipment in Southeast Asia and Middle East regions.
• SMMedicare IncorporatedcoreChannel Partner/ Reseller/ DistributorExclusive distributor for South Korea. Located at Hallim Human Tower, Gunpo-si, Gyeonggi-do, Republic of Korea. Contact: +82 (0)31 458-3188, [email protected]
• EMIRAL Congress Bureau, S.L.coreChannel Partner/ Reseller/ DistributorDistributor for Spain market. Located at Avenida Gran Capitán 46, 2ª, Oficina 4, 14006 Córdoba, Spain. Contact: (+34) 957 080 733, [email protected]
• MAG Biotech Trading Co., Ltd.minorChannel Partner/ Reseller/ DistributorDistributor for Taiwan market. Located at 7F-5, No. 205, Sec. 1, Dunhua S. Rd., Da'an Dist., Taipei City 10690, Taiwan (R.O.C.)
• LOGNORD TECHNOLOGY s.r.o.minorChannel Partner/ Reseller/ DistributorDistributor for Slovakia and Czech Republic. Located at A.Stefanku 6/1, 96501 Žiar nad Hronom, Slovakia. Contact: (+421) 905 202 805, [email protected], represented by Ing. Martin Ľupták, PhD.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Oncotherm: Oncotherm develops capacitive radiofrequency systems for oncological hyperthermia. It is a direct peer because it addresses the same oncology customers and treatment category using a closely related energy-delivery architecture.
• Pyrexar Medical: Pyrexar Medical provides deep and superficial hyperthermia systems and applicators for cancer treatment. It is directly comparable as a specialist supplier of hospital-based thermal oncology equipment, although its core deep-heating architecture differs from Andromedic's capacitive RF approach.
• Celsius42: Celsius42 develops specialist medical hyperthermia systems for oncology providers. It is a direct peer because it targets the same energy-based cancer-treatment category and hospital equipment purchasing motion.
• Yamamoto Co., Ltd. Yamamoto Co. develops and supplies radiofrequency capacitive hyperthermia equipment for oncological treatment. It is closely comparable to Andromedic in modality, customer type, and product positioning.

Emerging players

• Hydrosun: Hydrosun provides water-filtered infrared-A hyperthermia systems for medical use. It overlaps with Andromedic in hospital-based oncological heating equipment, but focuses more on local or superficial treatment rather than deep capacitive RF delivery.
• MagForce AG: MagForce develops NanoTherm therapy, which uses magnetic nanoparticles to generate localized tumor heating. It is comparable as a specialist thermal-oncology technology company serving cancer centers, although its delivery mechanism is materially different.
• Profound Medical: Profound Medical commercializes the TULSA-PRO platform for MRI-guided transurethral ultrasound ablation of prostate tissue. It is an emerging peer in hospital-based thermal cancer treatment, with a different anatomical focus and energy-delivery mechanism.
• EDAP TMS: EDAP TMS develops focused-ultrasound platforms used in urology and other therapeutic applications. It competes for similar clinical budgets and oncology equipment relationships, but delivers treatment through high-intensity focused ultrasound rather than radiofrequency hyperthermia.
• Novocure: Novocure provides Tumor Treating Fields therapy to oncology patients and providers. It is comparable in the broader electromodulation and cancer-treatment market, although it uses a nonthermal, wearable electric-field platform rather than hospital hyperthermia equipment.

Broad incumbents

• Elekta: Elekta is an established provider of radiation-therapy and oncology-care systems. It is a broad incumbent because it overlaps with Andromedic in radiation-oncology budgets and hospital workflows, but does not specialize in hyperthermia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• YouTubeyoutube.com/channel/UCX2hY-pZUc3ma5RPNLagglA
• Facebookfacebook.com/Andromedic-Srl-294054800702090
• LinkedInlinkedin.com/company/andromedic-srl

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Andromedic